Home / News

News

Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Company announcement

Kindeva appoints Joanna Disley as VP, Brand Strategy

Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Joanna Disley as VP, Brand Strategy to drive its brand, marketing and communications strategy. In this pivotal role, Joanna will be responsible for driving Kindeva’s overall brand, marketing and communications strategy. Joanna has extensive experience in marketing and communications which includes […]

Live-attenuated VEEV vaccine delivered by iDNA using microneedles is immunogenic in rabbits

March 11, 2022 – Medigen, Inc’s Dr. Irina Tretyakova and Dr. Peter Pushko in collaboration with Dr. John Vasilakos (Kindeva) and Dr. Tomai (3M) have published the manuscript titled Live-Attenuated VEEV Vaccine Delivered by iDNA using Microneedles is Immunogenic in Rabbits in Frontiers in Tropical Diseases, 2 Mar 2022. The authors demonstrate induction of neutralizing […]

Viatris Inc. announces receipt of the first FDA approval for generic version of Symbicort® inhalation aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate inhalation aerosol), in partnership with Kindeva

PITTSBURGH and ST. PAUL, Minn., March 16, 2022 — Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that, Mylan Pharmaceuticals Inc., a Viatris subsidiary, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for BreynaTM (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), the first approved generic version of AstraZeneca’s Symbicort®. Breyna, […]

Kindeva Drug Delivery to manufacture new, greener inhalers at UK manufacturing site to help cut carbon emissions

February 16, 2022 – One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions. The new inhalers will […]

Let’s transform tomorrow together

Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.

Let’s make your future